Welcome to the Chris Getten podcast where we dive deep into the science of building a stronger physique,

unlocking the secrets of anti-aging and optimizing your health through cutting edge biohacks,

fitness strategies and mental resilience. I've been a personal trainer for nearly 30 years now and voted the number one transformation

trainer by governing bodies such as PT Academy, bodybuilding.com and trainerize.

I am the co-founder of unmatched supplements, co-founder of the Chris Kathleenethyn Jims franchise, and co-founder of my

online coaching platform, Chris Kethin Coaching, and author of several books.

I'm a hybrid athlete, a natural pro bodybuilder, and I've competed in events such as Ironman

Triathlon, Ultramarathon, Spartan, and many more. My goal with this podcast is to cut through

the noise of fitness myth, misconceptions, and deliver clear protocols, actual tips, and real

resilience and science to help you optimize your physique, elevate your physical and mental

health span, and, of course, enhance your

life. Good morning, everybody. Now, welcome to the Chris Gethin podcast. Now, a lot of people, a lot of

clients have asked me about GLP ones, or Ozympic or Manjaro. And, you know, it's obviously very,

very popular now. It's got to the mainstream. Celebrities are taking it. Obviously, over-weight

people are taking it, and it's spreading. And I think we are about to double the amount of people

that have experimented with one of these GLPs, namely GLP-1s, like I said,

OZempic and Manjaro over the coming year, almost double, which is crazy.

So we want to ensure that we cover everything to ensure that people are utilizing something like

this accordingly and in an adult-like manner, and you use it and abuse it.

But Ozympic or semi-glutide is a GLP1 receptor agonist that was originally developed

to manage blood sugar in type 2 diabetics.

But their effect on appetite suppression and weight loss has led to widespread off-label use. So a 2023 report from Commodo Health

...